These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma. Gueye NA; Mead TJ; Koch CD; Biscotti CV; Falcone T; Apte SS J Clin Endocrinol Metab; 2017 May; 102(5):1631-1641. PubMed ID: 28323982 [TBL] [Abstract][Full Text] [Related]
5. Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR. Palijan A; Fernandes I; Bastien Y; Tang L; Verway M; Kourelis M; Tavera-Mendoza LE; Li Z; Bourdeau V; Mader S; Yang XJ; White JH J Biol Chem; 2009 Oct; 284(44):30264-74. PubMed ID: 19744931 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta is not increasingly expressed in leiomyoma nodules which show no progressive enlargement in premenopausal women. Roan CJ; Chuang JH; Hsu TY; Tsai HY; Pan LL; Cheng JT J Formos Med Assoc; 2005 Dec; 104(12):920-6. PubMed ID: 16607449 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium. Hermon TL; Moore AB; Yu L; Kissling GE; Castora FJ; Dixon D Virchows Arch; 2008 Dec; 453(6):557-69. PubMed ID: 18853184 [TBL] [Abstract][Full Text] [Related]
8. Protein expression of estrogen receptors α and β and aromatase in myometrium and uterine leiomyoma. Grings AO; Lora V; Ferreira GD; Brum IS; Corleta Hv; Capp E Gynecol Obstet Invest; 2012; 73(2):113-7. PubMed ID: 22377971 [TBL] [Abstract][Full Text] [Related]
9. [Effects of metformin on the expression of estrogen synthetase and ER mRNA in uterine leiomyoma tissues]. Wang SY; Xue Q; Zhou YF; Yin L Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):249-254. PubMed ID: 31006191 [No Abstract] [Full Text] [Related]
10. Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK. Zhu Y; Zhang T; Xie S; Tu R; Cao Y; Guo X; Zhou J; Zhou X; Cao L Biomed Pharmacother; 2012 Dec; 66(8):569-77. PubMed ID: 23102719 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro. Shen Y; Wu Y; Lu Q; Zhang P; Ren M Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478 [TBL] [Abstract][Full Text] [Related]
12. Cadmium and proliferation in human uterine leiomyoma cells: evidence of a role for EGFR/MAPK pathways but not classical estrogen receptor pathways. Gao X; Yu L; Moore AB; Kissling GE; Waalkes MP; Dixon D Environ Health Perspect; 2015 Apr; 123(4):331-6. PubMed ID: 25343777 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation. Afrin S; El Sabeh M; Islam MS; Miyashita-Ishiwata M; Malik M; Catherino WH; Akimzhanov AM; Boehning D; Yang Q; Al-Hendy A; Segars JH; Borahay MA Pharmacol Res; 2021 Oct; 172():105856. PubMed ID: 34461224 [TBL] [Abstract][Full Text] [Related]
14. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment. Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769 [TBL] [Abstract][Full Text] [Related]
15. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status. Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271 [TBL] [Abstract][Full Text] [Related]
17. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen. Howe SR; Pass HI; Ethier SP; Matthews WJ; Walker C Cancer Res; 1996 Sep; 56(17):4049-55. PubMed ID: 8752178 [TBL] [Abstract][Full Text] [Related]
18. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142 [TBL] [Abstract][Full Text] [Related]
19. Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine myometrium and leiomyoma. Mito K; Tamura T; Hosokawa K; Kondo T; Yamamoto T; Honjo H J Steroid Biochem Mol Biol; 1998 Oct; 67(1):9-16. PubMed ID: 9780024 [TBL] [Abstract][Full Text] [Related]
20. Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells. Azuma K; Urano T; Horie-Inoue K; Hayashi S; Sakai R; Ouchi Y; Inoue S Cancer Res; 2009 Apr; 69(7):2935-40. PubMed ID: 19318565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]